Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications (Q31867049)

4 July 2017

1 reference

title

Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications (English)

1 reference

4 July 2017

Nagane M

1

1 reference

4 July 2017

Lin H

series ordinal

2

1 reference

4 July 2017

Cavenee WK

series ordinal

3

1 reference

4 July 2017

Huang HJ

series ordinal

4

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

162 Suppl

1 reference

4 July 2017

page(s)

S17-S21

1 reference

Advances in the molecular genetics of gliomas.

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Molecular pathogenesis of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Specific targeting of a mutant, activated egf receptor found in glioblastoma using a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: comparison with its murine parent

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900648-0

7 January 2021

10.1016/S0304-3835(00)00648-0

Identifiers

DOI

1 reference

4 July 2017

1 reference